Jan. 25, 2018 Price forecast | 2 weeks: 3.49% | 1 month: 6.00% | 3 months: 7.89%


MNLO stock forecast

Our latest prediction for Menlo Therapeutics, Inc.'s stock price was made on the Jan. 25, 2018 when the stock price was at 28.71$.

In the short term (2weeks), MNLO's stock price should outperform the market by 3.49%. During that period the price should oscillate between -2.76% and +3.48%.

In the medium term (3months), MNLO's stock price should outperform the market by 7.89%. During that period the price should oscillate between -4.83% and +10.02%.


About Menlo Therapeutics, Inc.

Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded in October, 2011 and is headquartered in Redwood City, CA.

At the moment the company generates 13M USD in revenues.

On its last earning announcement, the company reported a loss of -1.86$ per share.

The book value per share is 6.88$

Menlo Therapeutics, Inc. website


Three months stock forecastJan. 25, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
13M - -46M -339.70% -43M -1.86 - - 23M 6.88 -46M - -46M